Funding for this research was provided by:
Beijing Hope RUN Special Fund of Cancer Foundation of China
Received: 26 April 2022
Accepted: 26 April 2022
First Online: 5 May 2022
: This prospective study was approved by the Ethics Committee of National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (NO: 21/096-2767). All participants provided written informed consent prior to entering the study.
: Not applicable.
: The authors declare that they have no competing interests.